Life Sciences

Topics • Chemistry

Rentschler Expands European Manufacturing Capabilities with GE Bioprocess Technologies

News

GE Healthcare Life Sciences and Rentschler Mark Handover

News

Evonik to Acquire Indian Specialty Catalyst Maker

News

Baumann Says He’ll Fight to Keep Bayer Independent

Topics • Strategy

Profitable Growth in Specialty Chemicals

Topics • Strategy

GE Healthcare Life Sciences With New Istanbul Center

News

After Tech Success, Israel Seeks Life Sciences Growth

Topics • Logistics

Interview with Angelos Orfanos, DHL: Life Science Demands Advanced Infrastructure

Topics • Technology

EMD Millipore, Sistemic Collaborate to Identify Control Markers for Stem Cell Production

News

Venture Firms See Signs of Rebirth in Life Sciences

News

Novasep Invests €3 Million to Boost its HPAPI Manufacturing Capabilities

Top-Feature

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

CHEManager International c/o Wiley-VCH GmbH

Predictive Simulation in Pharma Production

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

SCIEX

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Citrine

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Interview

Trade and Competitiveness

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Ontario Int. Marketing Ct.

Austrian Business Agency

Fluor Corporation

Bayer AG

KPMG AG Wirtschaftsprüfungsges.

Lonza AG

KPMG

Deutsche Post DHL

WeylChem International GmbH

Roland Berger GmbH

LISA Life Science Austria

Azelis Corporate Services NV

Horváth AG

Chemical Market Reporter

Camelot Management Consultants AG

Life Sciences

DSM Reorganizes to Cut Costs and Strengthen Focus

Roche Agrees to Buy Kapa Biosystems to Boost Next-generation Portfolio

A Whole New Range of New Services

UK Life Science Funding Hits 10-Year High

Is Big Data the Next Big Thing?

PwC Sees Pharmaceuticals, Life Sciences in M&A Surge

Rentschler Expands European Manufacturing Capabilities with GE Bioprocess Technologies

GE Healthcare Life Sciences and Rentschler Mark Handover

Evonik to Acquire Indian Specialty Catalyst Maker

Baumann Says He’ll Fight to Keep Bayer Independent

Profitable Growth in Specialty Chemicals

The Formula For Success

GE Healthcare Life Sciences With New Istanbul Center

Lonza’s Corporate Overhaul

After Tech Success, Israel Seeks Life Sciences Growth

Interview with Angelos Orfanos, DHL: Life Science Demands Advanced Infrastructure

Breaking New Ground

Global Meets Local in Austria

EMD Millipore, Sistemic Collaborate to Identify Control Markers for Stem Cell Production

Venture Firms See Signs of Rebirth in Life Sciences

Novasep Invests €3 Million to Boost its HPAPI Manufacturing Capabilities

Top-Feature

Siemens Joins the Global Impact Coalition

Upcoming Virtual Events

Predictive Simulation in Pharma Production

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Interview

The UK Chemical Supply Chain

Life Sciences

Top-Feature

Siemens Joins the Global Impact Coalition

Upcoming Virtual Events

Predictive Simulation in Pharma Production

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Interview

Newsletter & e-edition